Miller KD - Search Results

1

A phase II study of weekly oral methotrexate and zidovudine (AZT) in advanced adenocarcinoma of the pancreas and hepatocellular carcinoma.

Miller KD, Loehrer PJ, Gonin R, Weber G, Ansari R, Pletcher W, McClean J, Spiridonidis CH, Mortimer J. Miller KD, et al. Invest New Drugs. 1996;14(2):207-12. doi: 10.1007/BF00210792. Invest New Drugs. 1996. PMID: 8913842 Clinical Trial.

2

Salvage chemotherapy with vinblastine, ifosfamide, and cisplatin in recurrent seminoma.

Miller KD, Loehrer PJ, Gonin R, Einhorn LH. Miller KD, et al. J Clin Oncol. 1997 Apr;15(4):1427-31. doi: 10.1200/JCO.1997.15.4.1427. J Clin Oncol. 1997. PMID: 9193335

3

Combination versus sequential doxorubicin and docetaxel as primary chemotherapy for breast cancer: A randomized pilot trial of the Hoosier Oncology Group.

Miller KD, McCaskill-Stevens W, Sisk J, Loesch DM, Monaco F, Seshadri R, Sledge GW Jr. Miller KD, et al. J Clin Oncol. 1999 Oct;17(10):3033-7. doi: 10.1200/JCO.1999.17.10.3033. J Clin Oncol. 1999. PMID: 10506597 Clinical Trial.

4

Phase II study of the multitargeted antifolate LY231514 (ALIMTA, MTA, pemetrexed disodium) in patients with advanced pancreatic cancer.

Miller KD, Picus J, Blanke C, John W, Clark J, Shulman LN, Thornton D, Rowinsky E, Loehrer PJ Sr. Miller KD, et al. Ann Oncol. 2000 Jan;11(1):101-3. doi: 10.1023/a:1008305205159. Ann Oncol. 2000. PMID: 10690396 Free article. Clinical Trial.

5

Toward checkmate: biology and breast cancer therapy for the new millennium.

Miller KD, Sledge GW Jr. Miller KD, et al. Invest New Drugs. 1999;17(4):417-27. doi: 10.1023/a:1006311227965. Invest New Drugs. 1999. PMID: 10759407 Review.

6

Gemcitabine, paclitaxel, and trastuzumab in metastatic breast cancer.

Miller KD, Sisk J, Ansari R, Gize G, Nattam S, Pennington K, Monaco F, Sledge GW Jr. Miller KD, et al. Oncology (Williston Park). 2001 Feb;15(2 Suppl 3):38-40. Oncology (Williston Park). 2001. PMID: 11252888 Clinical Trial.

7

Combined anti-microtubule therapy: a phase II study of weekly docetaxel plus estramustine in patients with metastatic breast cancer.

Soule SE, Miller KD, Porcu P, Ansari R, Fata F, McClean JW, Zon R, Sledge GW, Einhorn LH. Soule SE, et al. Among authors: miller kd. Ann Oncol. 2002 Oct;13(10):1612-5. doi: 10.1093/annonc/mdf283. Ann Oncol. 2002. PMID: 12377650 Free article. Clinical Trial.

8

A phase II study of 9-nitro-camptothecin in patients with previously treated metastatic breast cancer.

Miller KD, Soule SE, Haney LG, Guiney P, Murry DJ, Lenaz L, Sun SL, Sledge GW Jr. Miller KD, et al. Invest New Drugs. 2004 Jan;22(1):69-73. doi: 10.1023/b:drug.0000006176.84915.71. Invest New Drugs. 2004. PMID: 14707496 Clinical Trial.

9

Phase I safety, pharmacokinetic and pharmacodynamic studies of 2-methoxyestradiol alone or in combination with docetaxel in patients with locally recurrent or metastatic breast cancer.

James J, Murry DJ, Treston AM, Storniolo AM, Sledge GW, Sidor C, Miller KD. James J, et al. Among authors: miller kd. Invest New Drugs. 2007 Feb;25(1):41-8. doi: 10.1007/s10637-006-9008-5. Epub 2006 Sep 13. Invest New Drugs. 2007. PMID: 16969706 Clinical Trial.

10

A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimen.

Mina L, Krop I, Zon RT, Isakoff SJ, Schneider CJ, Yu M, Johnson C, Vaughn LG, Wang Y, Hristova-Kazmierski M, Shonukan OO, Sledge GW, Miller KD. Mina L, et al. Among authors: miller kd. Invest New Drugs. 2009 Dec;27(6):565-70. doi: 10.1007/s10637-009-9220-1. Epub 2009 Feb 13. Invest New Drugs. 2009. PMID: 19214387 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

525 results

Search Page

Filters